Concerns rise as anti-vaccine views in government threaten the approval process for new vaccines awaiting FDA and regulatory review in 2025.
ASSURE In the News
Concerns rise as anti-vaccine views in government threaten the approval process for new vaccines awaiting FDA and regulatory review in 2025.
Explore the latest on the Novavax COVID-19 vaccine delay and RFK Jr.’s false claims about vaccine safety, with facts from experts and public health agencies.
Explore the impact of recent federal workforce reductions on employee morale within the FDA, CDC, and other HHS agencies in Washington, D.C.
Explore the potential impacts of Robert F. Kennedy Jr.’s appointment as HHS Secretary on vaccine policies and CDC operations, amidst concerns over public health initiatives.
Explore how the Department of Health and Human Services, including changes to the FDA and CDC, can influence COVID-19 response strategies in 2025.
Explore the effectiveness of rapid COVID-19 testing in 2025, its role in preventing virus spread, and insights from health experts and agencies.
Matthew Memoli, new acting NIH head: his views on COVID-19, vaccines, and the US pandemic response. Learn about his vision and implications for public health.
Explore potential changes to the FDA under the Trump administration and their impact on COVID-19 management, testing, vaccines, and public health.
Learn how the new administration is addressing COVID-19 cases and resources. Explore changes in public health strategies, rapid testing, and vaccination efforts